Transplantation and Cellular Therapy
Издатель: Elsevier · ISSN 2666-6367 · 90 статей
- Long-term follow-up of relapsed/refractory large B-cell lymphoma patients treated with salvage immunochemotherapy
- Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: Key Clinical Questions and Lessons from a Single-Center Experience
- Predictors of refractory CMV infection in children with haematological malignancies after allogeneic HSCT
- Prospective Multi-Institutional Validation of a Practical Eculizumab Dosing Regimen for Transplant-Associated Thrombotic Microangiopathy in Children and Young Adults
- Attainment of Prophylactic Target Posaconazole Concentrations During Admission for Allogeneic Stem Cell Transplant
- Officers and Directors of ASTCT
- Table of Contents
- Betrayed by My Marrow: Is There Something to Learn From It?
- The Bottom Line: OOS Cilta-cel in MM
- CAR T Cells Before HCT: Reassuring Safety, but Uncertain Benefit
- Challenges With Expansion of Cell and Gene Therapy: A Call for System-Level Action
- A Comprehensive Rehabilitation Framework to Help Optimize Outcomes Across the CAR-T Continuum—White Paper Report
- Beyond Conventional Chimeric Antigen Receptors: Expanding the Targetable Antigen Landscape in Chimeric Antigen Receptor-T Cell Therapy
- Chimeric Antigen Receptor-Based Cellular Therapies for Autoimmune Diseases: Immune Reset, Clinical Evidence, and Translational Boundaries
- Comparison of Carmustine-, Lomustine-, and Nitrosourea-Free Conditioning Regimens for Autologous HCT (Auto-HCT) in Lymphoma: Results From the Hematopoietic Cell Transplantation Brazilian Registry (HCTBR)
- Haploidentical Versus HLA-matched Unrelated Donors for Hematopoietic Cell Transplantation in Acute Leukemia: A Multicenter Observational Study in a Developing Country Facilitated by Collaboration Between the CIBMTR and the Brazilian Society of Cellular Therapy and Bone Marrow Transplantation (SBTMO)
- Real-World Safety, Efficacy, and Immune Recovery Following Out-of-Specification Ciltacabtagene Autoleucel in Multiple Myeloma
- Combination of Ruxolitinib and Extracorporeal Photopheresis as Third or Subsequent Line of Therapy for Steroid-dependent/Resistant Acute and Chronic GVHD
- Reduced-Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation with Once-Daily Intravenous Busulfan for Relapsed/Refractory Lymphoma: A Phase II Study
- Enhancing Rigor, Reproducibility, and Replicability in Biobehavioral Research: Expert Recommendations from the Biobehavioral Research Special Interest Group of ASTCT
- Exercise Prehabilitation for Older Adults Undergoing CAR-T: Feasibility, Acceptability, and Preliminary Outcomes
- Predictors of Rehabilitation Utilization After CAR T-Cell Therapy
- Harnessing the Power of Two: High-Dose Stem Cell Haploidentical Transplant in Hematologic Malignancies: A Prospective Trial
- Safety and Outcomes of CD19 CAR-T Cell Therapy in Splenectomized Patients With B-Cell Lymphomas
- Clinical Impact of Discordant Minimal Residual Disease Assessment in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
- Integrated Analysis of Hematopoietic Changes Following Heterochronic Bone Marrow Transplantation Between Young and Aged Mice
- Cis-targeted IL-2 Mutein to Augment the Antitumor Activity of Engineered T Cells
- Impact of Prior Bendamustine Exposure on Chimeric Antigen Receptor T-Cell Therapy Outcomes in Follicular Lymphoma
- Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall Survival
- Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma